. home.aspx

NEWS

home.aspx
   


AZ farms out rare disease therapy to Mereo

October 31, 2017 / Selina McKee
SHARESHARESHARE

AstraZeneca has licensed an experimental rare disease therapy to UK-based Mereo BioPharma, as it continues to shed products outside of its area of strategic focus.